(Q45863185)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Determinants of drug costs in hopitalised patients with haemophilia: impact of recombinant activated factor VII (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

Nathalie Pelletier-Fleury

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Jean Philippe Galanaud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Hélène Logerot-Lebrun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Thierry Lambert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

699-707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12828492%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-200321100-00002

5 November 2019

exact match

0 references

cites work

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

1 reference

12 December 2020

Haemophilia treatment protocols around the world: towards a consensus

1 reference

12 December 2020

Factor VIII inhibitor treatment. Economics of inhibitor treatment in Canada.

1 reference

12 December 2020

Pharmaco-economic aspects of inhibitor treatment.

1 reference

12 December 2020

The impact of inhibitors on the cost of clotting factor replacement therapy in Haemophilia A in Canada

1 reference

12 December 2020

Prophylactic use of factor VIII: an economic evaluation

1 reference

12 December 2020

Mortality and causes of death in Dutch haemophiliacs, 1973-86.

1 reference

12 December 2020

Cost-utility analysis of recombinant factor VIIa (NovoSeven) in six children with long-standing inhibitors to factor VIII or IX.

1 reference

12 December 2020

Protocols for the treatment of haemophilia and von Willebrand disease

1 reference

12 December 2020

Prevalence of inhibitors in a population of 3435 hemophilia patients in France. French Hemophilia Study Group

1 reference

12 December 2020

Resource utilisation in haemophiliacs treated in Europe: results from the European Study on Socioeconomic Aspects of Haemophilia Care. The European Socioeconomic Study Group

1 reference

12 December 2020

Inhibitors in haemophilia: a primer

1 reference

12 December 2020

Socioeconomic impact of haemophilia care: results of a pilot study

1 reference

12 December 2020

Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitor

1 reference

12 December 2020

The economics of factor VIII inhibitor treatment.

1 reference

12 December 2020

1 reference

12 December 2020

Home treatment with recombinant activated factor VII: results from one centre.

1 reference

12 December 2020

Gene therapy for hemophilia

1 reference

12 December 2020

High cost, low volume care: the case of haemophilia

1 reference

12 December 2020

Economic aspects of haemophilia care in the United States

1 reference

12 December 2020

Economic aspects of haemophilia care

1 reference

12 December 2020

Hemophilia home treatment. Economic analysis and implications for health policy

1 reference

12 December 2020

Costs for acute myocardial infarction in a tertiary care centre and nationwide in France

1 reference

12 December 2020

The hemophilias--from royal genes to gene therapy

1 reference

12 December 2020